STOCK TITAN

Strata Skin Sciences Stock Price, News & Analysis

SSKN NASDAQ

Company Description

Overview of Strata Skin Sciences Inc

Strata Skin Sciences Inc (SSKN) is a dynamic medical technology company that specializes in the development, commercialization, and marketing of innovative in-office treatments for a variety of dermatologic conditions. By leveraging advanced medical technologies such as excimer lasers and specialized lamp systems, the company addresses complex dermatological issues including psoriasis, vitiligo, and acne. These critical treatment modalities are part of an integrated approach that combines state-of-the-art devices with a robust partnership program and comprehensive procedural support.

Core Business Segments and Revenue Model

The company operates through two primary segments:

  • Dermatology Recurring Procedures: This segment is fundamental to the company’s revenue stream. It is based on a fee per treatment model wherein dermatologists perform standardized procedures using the company’s specialized equipment. This model not only fosters ongoing patient management but also reinforces a recurring revenue cycle that is embedded within routine dermatologic practice.
  • Dermatology Procedures Equipment: In addition to recurring treatment fees, Strata Skin Sciences generates revenue from the sale of its sophisticated treatment equipment. This includes devices like the XTRAC excimer laser and VTRAC lamp systems, which are designed to offer precise treatment options in an in-office setting.

Strata Skin Sciences’ business model emphasizes a comprehensive partnership approach. Rather than relying solely on equipment sales, the company offers a full-service program that includes installation, on-site training for practice personnel, maintenance, and customer support. This integrated service package is designed to enhance treatment efficacy and operational efficiency within dermatology clinics.

Innovative Technology and Clinical Impact

The company stands out due to its commitment to innovation and clinical excellence. Key products, such as the XTRAC excimer laser and associated lamp systems, harness precise phototherapy techniques that deliver targeted treatments with minimal side effects. These technologies are developed with a deep understanding of skin biology and are often utilized in cases where traditional treatments have had limited effectiveness.

Moreover, Strata Skin Sciences emphasizes technological refinement combined with a patient-centric approach. The company does not view its products merely as devices; rather, it positions them as tools of hope and optimism. The assurance of quality, performance, and comprehensive clinical support is central to its value proposition in the medical technology sector.

Industry Position and Competitive Landscape

Within the broader realm of dermatology and medical device industries, Strata Skin Sciences occupies a unique niche. The market for dermatologic treatments is highly specialized and demands both technological precision and robust clinical support. Several competitors exist in the realm of phototherapy devices; however, the company’s dual focus on recurring procedural revenue and equipment sales, coupled with its comprehensive partnership program, distinguishes it from traditional business models. By ensuring that its technology is paired with extensive training and support, Strata Skin Sciences builds strong relationships with dermatology practices, reinforcing its competitive edge.

Operational Strategy and Market Significance

The operational strategy of Strata Skin Sciences is meticulously designed to harness the benefits of both direct technology utilization and long-term partner relationships. The company’s emphasis on recurring procedures means that treatment sessions are not isolated events but part of a continuous patient care model. This not only supports predictable revenue generation but also promotes sustained engagement with clinical partners.

Furthermore, with a predominant presence in the United States, Strata Skin Sciences effectively taps into a market characterized by mature healthcare practices and a high demand for advanced dermatologic treatments. The company’s integrative approach—combining advanced equipment with essential services such as training, maintenance, and marketing support—furthers its relevance and appeal to dermatologists looking for reliable, quality solutions.

Customer-Centric Partnership Program

A notable aspect of the company is its unique partnership program. Designed to create a win-win environment for both the company and dermatology practices, the program offers a fee per treatment model rather than a traditional equipment purchase. This approach reduces the upfront cost burden on clinics and facilitates a more seamless integration of advanced dermatologic treatments into everyday practice. In return, practices gain access to cutting-edge technology, on-site training, and ongoing technical support, which together enhance treatment outcomes and improve patient satisfaction.

Commitment to Innovation, Quality, and Support

At its core, Strata Skin Sciences is driven by a mission to transform the standard of care in dermatology. The company’s extensive investment in research and development is evident in the continued evolution of its products and treatment programs. This dedication to innovation is complemented by an acute focus on quality control, clinical efficacy, and customer support, ensuring that each product delivers on its promise of advanced, effective, and safe dermatologic care.

Conclusion

Strata Skin Sciences Inc epitomizes the convergence of technological prowess and patient-centered clinical service. Its strategic emphasis on dual revenue streams—through recurring treatment procedures and state-of-the-art equipment sales—positions it as a distinct entity in the medical technology sector. By continuously refining its devices and expanding its partnership programs, the company not only addresses unmet clinical needs but also reinforces its role as a trusted provider of innovative dermatologic solutions. This comprehensive approach, grounded in industry expertise and a deep commitment to quality, underscores the significance of Strata Skin Sciences for dermatologists and the broader medical community.

Stock Performance

$—
0.00%
0.00
Last updated:
-44.05 %
Performance 1 year
$10.5M
Market Cap
4.2M
Shares outstanding

SEC Filings

No SEC filings available for Strata Skin Sciences.

Financial Highlights

$33,562,000
Revenue (TTM)
-$10,086,000
Net Income (TTM)
-$2.65
Diluted EPS (TTM)
$188,000
Operating Cash Flow
-30.05%
Net Profit Margin
-27.58%
Oper. Profit Margin

Upcoming Events

Frequently Asked Questions

What is the current stock price of Strata Skin Sciences (SSKN)?

The current stock price of Strata Skin Sciences (SSKN) is $2.62 as of April 24, 2025.

What is the market cap of Strata Skin Sciences (SSKN)?

The market cap of Strata Skin Sciences (SSKN) is approximately 10.5M.

What is the revenue (TTM) of Strata Skin Sciences (SSKN) stock?

The trailing twelve months (TTM) revenue of Strata Skin Sciences (SSKN) is $33,562,000.

What is the net income of Strata Skin Sciences (SSKN)?

The trailing twelve months (TTM) net income of Strata Skin Sciences (SSKN) is -$10,086,000.

What is the earnings per share (EPS) of Strata Skin Sciences (SSKN)?

The diluted earnings per share (EPS) of Strata Skin Sciences (SSKN) is -$2.65 on a trailing twelve months (TTM) basis.

What is the operating cash flow of Strata Skin Sciences (SSKN)?

The operating cash flow of Strata Skin Sciences (SSKN) is $188,000.

What is the profit margin of Strata Skin Sciences (SSKN)?

The net profit margin of Strata Skin Sciences (SSKN) is -30.05%.

What is the operating margin of Strata Skin Sciences (SSKN)?

The operating profit margin of Strata Skin Sciences (SSKN) is -27.58%.

What is the gross margin of Strata Skin Sciences (SSKN)?

The gross profit margin of Strata Skin Sciences (SSKN) is 56.85%.

What is the current ratio of Strata Skin Sciences (SSKN)?

The current ratio of Strata Skin Sciences (SSKN) is 1.13, indicating the company's ability to pay short-term obligations.

What is the gross profit of Strata Skin Sciences (SSKN)?

The gross profit of Strata Skin Sciences (SSKN) is $19,081,000 on a trailing twelve months (TTM) basis.

What is the operating income of Strata Skin Sciences (SSKN)?

The operating income of Strata Skin Sciences (SSKN) is -$9,255,000.

What is Strata Skin Sciences Inc?

Strata Skin Sciences Inc is a medical technology company that develops, commercializes, and markets innovative in-office treatment devices for dermatologic conditions, including psoriasis, vitiligo, and acne.

How does the company generate its revenue?

The company generates revenue through its Dermatology Recurring Procedures segment that charges a fee per treatment and its Dermatology Procedures Equipment segment that sells advanced treatment devices. This dual model combines recurring services with equipment sales.

What are the key products offered by Strata Skin Sciences Inc?

The company offers advanced technologies such as the XTRAC excimer laser and VTRAC lamp systems, along with other treatment systems designed for effective in-office management of various dermatological conditions.

What distinguishes Strata Skin Sciences from its competitors?

Its comprehensive partnership program, which includes on-site training, maintenance, and marketing support, sets it apart. This service-oriented approach complements its state-of-the-art equipment, ensuring sustainable clinical use and recurring revenue benefits.

What conditions are primarily treated using the company’s technologies?

Strata Skin Sciences' devices are primarily used in the treatment of psoriasis, vitiligo, and acne. These technologies target specific skin conditions with precise and controlled treatment methodologies.

How does the partnership program benefit dermatology clinics?

By offering a fee per treatment model instead of a large upfront equipment cost, the partnership program makes it easier for clinics to adopt advanced treatment technologies. Clinics also benefit from continuous training, service, and promotional support, enhancing their treatment capabilities.